Kunz C - Search Results

1

Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings.

Moeker N, Peters S, Rauchenberger R, Ghinea N, Kunz C. Moeker N, et al. Among authors: kunz c. Antibodies (Basel). 2017 Oct 18;6(4):15. doi: 10.3390/antib6040015. Antibodies (Basel). 2017. PMID: 31548530 Free PMC article.

2

An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin.

Garner AP, Bialucha CU, Sprague ER, Garrett JT, Sheng Q, Li S, Sineshchekova O, Saxena P, Sutton CR, Chen D, Chen Y, Wang H, Liang J, Das R, Mosher R, Gu J, Huang A, Haubst N, Zehetmeier C, Haberl M, Elis W, Kunz C, Heidt AB, Herlihy K, Murtie J, Schuller A, Arteaga CL, Sellers WR, Ettenberg SA. Garner AP, et al. Among authors: kunz c. Cancer Res. 2013 Oct 1;73(19):6024-35. doi: 10.1158/0008-5472.CAN-13-1198. Epub 2013 Aug 8. Cancer Res. 2013. PMID: 23928993 Free PMC article.

3

Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.

Kunz C, Borghouts C, Buerger C, Groner B. Kunz C, et al. Mol Cancer Res. 2006 Dec;4(12):983-98. doi: 10.1158/1541-7786.MCR-06-0046. Mol Cancer Res. 2006. PMID: 17189388

4

Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition.

Borghouts C, Kunz C, Delis N, Groner B. Borghouts C, et al. Among authors: kunz c. Mol Cancer Res. 2008 Feb;6(2):267-81. doi: 10.1158/1541-7786.MCR-07-0245. Mol Cancer Res. 2008. PMID: 18314488

5

Peptide aptamers: recent developments for cancer therapy.

Borghouts C, Kunz C, Groner B. Borghouts C, et al. Among authors: kunz c. Expert Opin Biol Ther. 2005 Jun;5(6):783-97. doi: 10.1517/14712598.5.6.783. Expert Opin Biol Ther. 2005. PMID: 15952909 Review.

6

Current strategies for the development of peptide-based anti-cancer therapeutics.

Borghouts C, Kunz C, Groner B. Borghouts C, et al. Among authors: kunz c. J Pept Sci. 2005 Nov;11(11):713-26. doi: 10.1002/psc.717. J Pept Sci. 2005. PMID: 16138387 Review.

7

Peptide aptamer libraries.

Borghouts C, Kunz C, Groner B. Borghouts C, et al. Among authors: kunz c. Comb Chem High Throughput Screen. 2008 Feb;11(2):135-45. doi: 10.2174/138620708783744462. Comb Chem High Throughput Screen. 2008. PMID: 18336207 Review.

8

The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Desrivières S, Kunz C, Barash I, Vafaizadeh V, Borghouts C, Groner B. Desrivières S, et al. Among authors: kunz c. J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):75-87. doi: 10.1007/s10911-006-9014-4. J Mammary Gland Biol Neoplasia. 2006. PMID: 16947086 Review.

9

Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells.

Buerger C, Nagel-Wolfrum K, Kunz C, Wittig I, Butz K, Hoppe-Seyler F, Groner B. Buerger C, et al. Among authors: kunz c. J Biol Chem. 2003 Sep 26;278(39):37610-21. doi: 10.1074/jbc.M301629200. Epub 2003 Jul 2. J Biol Chem. 2003. PMID: 12842895 Free article.

10

Metabolic Investigation and Auxiliary Enzyme Modelization of the Pyrrocidine Pathway Allow Rationalization of Paracyclophane-Decahydrofluorene Formation.

Chen Y, Sewsurn S, Amand S, Kunz C, Pietrancosta N, Calabro K, Buisson D, Mann S. Chen Y, et al. Among authors: kunz c. ACS Chem Biol. 2024 Apr 19;19(4):886-895. doi: 10.1021/acschembio.3c00684. Epub 2024 Apr 4. ACS Chem Biol. 2024. PMID: 38576157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

671 results

Search Page